Gravol Chewables Motion Sickness Dimenhydrinate Tablet, Chewable
Product Images NDC 10237-943

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Gravol Chewables Motion Sickness Dimenhydrinate (NDC 10237-943). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Church & Dwight Co., Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (50 mg Blister Pack Carton)

Principal Display Panel (50 mg Blister Pack Carton)
Prevents and Treats: Nausea, Vomiting & Dizziness* with Gravol tablets containing Dimenhydrinate 50 mg for motion sickness. This medication helps in the prevention and treatment of symptoms like nausea, vomiting, and dizziness related to motion sickness.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.